Connor, Clark & Lunn Investment Management (CC&L)
HRMY icon

Connor, Clark & Lunn Investment Management (CC&L)’s Harmony Biosciences HRMY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83M Sell
101,110
-148,014
-59% -$4.85M 0.01% 855
2025
Q4 		$9.32M Buy
249,124
+17,228
+7% +$566K 0.02% 477
2025
Q3 		$6.39M Sell
231,896
-16,963
-7% -$584K 0.02% 518
2025
Q2 		$7.86M Buy
248,859
+134,649
+118% +$4.33M 0.03% 458
2025
Q1 		$3.79M Buy
+114,210
New +$4.09M 0.02% 574
2024
Q4 		– Sell
-8,974
Closed -$359K – 1497
2024
Q3 		$359K Buy
+8,974
New +$315K ﹤0.01% 1188
2023
Q4 		– Sell
-8,742
Closed -$286K – 1462
2023
Q3 		$286K Buy
+8,742
New +$303K ﹤0.01% 1155

Other funds holding HRMY

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return